ANI PHARMACEUTICALS, INC Amortization of Debt Issuance Costs
ANI PHARMACEUTICALS, INC (ANIP) reported Amortization of Debt Issuance Costs of $591.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2024-08-06
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs for the quarter ending 2024-06-30 was $591.00K, a 0.00% change year-over-year.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs for the quarter ending 2024-03-31 was $591.00K, a 0.00% change year-over-year.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs for the quarter ending 2023-12-31 was $591.00K, a 0.17% increase year-over-year.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs for the quarter ending 2023-09-30 was $591.00K, a 0.17% decline year-over-year.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs for fiscal 2023 was $2.36M, a 0.04% increase from fiscal 2022.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs for fiscal 2022 was $2.36M, a 158.53% increase from fiscal 2021.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs for fiscal 2021 was $914.00K, a 26.94% increase from fiscal 2020.
- ANI PHARMACEUTICALS, INC amortization of debt issuance costs for fiscal 2020 was $720.00K, a 47.71% decline from fiscal 2019.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2024-06-30 | $591.00K 10-Q · filed 2024-08-06 | $1.18M 10-Q · filed 2024-08-06 | $1.77M derived: sum of 3 quarters · filed 2024-08-06 | $2.36M derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | $591.00K 10-Q · filed 2024-05-10 | $1.18M derived: sum of 2 quarters · filed 2024-05-10 | $1.77M derived: sum of 3 quarters · filed 2024-05-10 | $2.36M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-12-31 | $591.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.18M derived: sum of 2 quarters · filed 2024-02-29 | $1.77M derived: sum of 3 quarters · filed 2024-08-06 | $2.36M 10-K · filed 2024-02-29 |
| 2023-09-30 | $591.00K 10-Q · filed 2023-11-08 | $1.18M derived: sum of 2 quarters · filed 2024-08-06 | $1.77M 10-Q · filed 2023-11-08 | $2.36M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-06-30 | $591.00K 10-Q · filed 2024-08-06 | $1.18M 10-Q · filed 2024-08-06 | $1.77M derived: sum of 3 quarters · filed 2024-08-06 | $2.36M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $591.00K 10-Q · filed 2024-05-10 | $1.18M derived: sum of 2 quarters · filed 2024-05-10 | $1.77M derived: sum of 3 quarters · filed 2024-05-10 | $2.36M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $590.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.18M derived: sum of 2 quarters · filed 2024-02-29 | $1.77M derived: sum of 3 quarters · filed 2024-02-29 | $2.36M 10-K · filed 2024-02-29 |
| 2022-09-30 | $592.00K 10-Q · filed 2023-11-08 | $1.18M derived: sum of 2 quarters · filed 2023-11-08 | $1.77M 10-Q · filed 2023-11-08 | $2.16M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $590.00K 10-Q · filed 2023-08-09 | $1.18M 10-Q · filed 2023-08-09 | $1.57M derived: sum of 3 quarters · filed 2024-02-29 | $1.74M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $591.00K 10-Q · filed 2023-05-08 | $978.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.15M derived: sum of 3 quarters · filed 2024-02-29 | $1.33M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $387.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $562.00K derived: sum of 2 quarters · filed 2024-02-29 | $738.00K derived: sum of 3 quarters · filed 2024-02-29 | $914.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $175.00K 10-Q · filed 2022-11-09 | $351.00K derived: sum of 2 quarters · filed 2022-11-09 | $527.00K 10-Q · filed 2022-11-09 | $706.00K derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-06-30 | $176.00K 10-Q · filed 2022-08-08 | $352.00K 10-Q · filed 2022-08-08 | $531.00K derived: sum of 3 quarters · filed 2023-03-09 | $711.00K derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-03-31 | $177.00K 10-Q · filed 2022-05-10 | $355.00K derived: sum of 2 quarters · filed 2023-03-09 | $535.00K derived: sum of 3 quarters · filed 2023-03-09 | $715.00K derived: sum of 4 quarters · filed 2023-03-09 |
| 2020-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $358.00K derived: sum of 2 quarters · filed 2023-03-09 | $538.00K derived: sum of 3 quarters · filed 2023-03-09 | $720.00K 10-K · filed 2023-03-09 |
| 2020-09-30 | $180.00K 10-Q · filed 2021-11-01 | $360.00K derived: sum of 2 quarters · filed 2021-11-01 | $542.00K 10-Q · filed 2021-11-01 | $841.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $180.00K 10-Q · filed 2021-08-06 | $362.00K 10-Q · filed 2021-08-06 | $661.00K derived: sum of 3 quarters · filed 2022-03-15 | $1.02M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $182.00K 10-Q · filed 2021-05-07 | $481.00K derived: sum of 2 quarters · filed 2022-03-15 | $839.00K derived: sum of 3 quarters · filed 2022-03-15 | $1.20M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $657.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.02M derived: sum of 3 quarters · filed 2022-03-15 | $1.38M 10-K · filed 2022-03-15 |
| 2019-09-30 | $358.00K 10-Q · filed 2020-11-05 | $718.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.08M 10-Q · filed 2020-11-05 | $1.43M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $360.00K 10-Q · filed 2020-08-06 | $720.00K 10-Q · filed 2020-08-06 | $1.07M derived: sum of 3 quarters · filed 2021-03-11 | $1.44M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $360.00K 10-Q · filed 2020-05-07 | $712.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.08M derived: sum of 3 quarters · filed 2021-03-11 | $1.45M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $722.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.09M derived: sum of 3 quarters · filed 2021-03-11 | $1.46M 10-K · filed 2021-03-11 |
| 2018-09-30 | $370.00K 10-Q · filed 2019-11-06 | $741.00K derived: sum of 2 quarters · filed 2019-11-06 | $1.11M 10-Q · filed 2019-11-06 | $1.32M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $371.00K 10-Q · filed 2019-08-07 | $741.00K 10-Q · filed 2019-08-07 | $953.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.16M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $370.00K 10-Q · filed 2019-05-09 | $582.00K derived: sum of 2 quarters · filed 2020-02-27 | $793.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $423.00K derived: sum of 2 quarters · filed 2020-02-27 | $634.00K derived: sum of 3 quarters · filed 2020-02-27 | $845.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $211.00K 10-Q · filed 2018-11-06 | $422.00K derived: sum of 2 quarters · filed 2018-11-06 | $633.00K 10-Q · filed 2018-11-06 | $844.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $211.00K 10-Q · filed 2017-08-03 | $422.00K 10-Q · filed 2018-08-07 | $633.00K derived: sum of 3 quarters · filed 2019-02-27 | $844.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $211.00K 10-Q · filed 2018-05-08 | $422.00K derived: sum of 2 quarters · filed 2019-02-27 | $633.00K derived: sum of 3 quarters · filed 2019-02-27 | $844.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $422.00K derived: sum of 2 quarters · filed 2019-02-27 | $633.00K derived: sum of 3 quarters · filed 2019-02-27 | $844.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $211.00K 10-Q · filed 2017-11-02 | $422.00K derived: sum of 2 quarters · filed 2017-11-02 | $633.00K 10-Q · filed 2017-11-02 | $844.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $211.00K 10-Q · filed 2017-08-03 | $422.00K 10-Q · filed 2017-08-03 | $633.00K derived: sum of 3 quarters · filed 2018-02-27 | $844.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $211.00K 10-Q · filed 2017-05-04 | $422.00K derived: sum of 2 quarters · filed 2018-02-27 | $633.00K derived: sum of 3 quarters · filed 2018-02-27 | $844.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $422.00K derived: sum of 2 quarters · filed 2018-02-27 | $633.00K derived: sum of 3 quarters · filed 2018-02-27 | $844.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | $211.00K 10-Q · filed 2016-11-03 | $422.00K derived: sum of 2 quarters · filed 2016-11-03 | $633.00K 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $211.00K 10-Q · filed 2016-08-04 | $422.00K 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $211.00K 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $70.00K 10-K · filed 2016-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |